● Recruiting

A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India

Condition: Severe Postpartum Haemorrhage · Sponsor: Novo Nordisk A/S

PhasePhase 4

Planned participants64

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will look at how safe is the medicine eptacog alfa when used in women in India for stopping heavy bleeding after giving birth. If participants have heavy bleeding after giving birth then they will get the medicine eptacog alfa. This study will be conducted to get more knowledge on the safety of the medicine eptacog alfa use in these women. At first participants will receive one dose of medicine eptacog alfa. If the given dose is not helpful to stop the bleeding, participants will get one additional dose. The study will last for about 30-35 days.

This description comes directly from the study's public registry record.

Talk to the study team

Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com

Always discuss trial participation with your own doctor first.

Locations (10)

KLE Belgum	Belagavi, Karnataka, India	Recruiting
Calicut Medical College	Kozhikode, Kerala, India	Recruiting
Calicut Medical College	Kozhikode, Kerala, India	Not Yet Recruiting
Seth GS Medical College & KEM Hospital	Mumbai, Maharashtra, India	Recruiting
All India Institute of Medical Sciences_New Dehli	New Delhi, National Capital Territory of Delhi, India	Recruiting
SMS Hospital	Jaipur, Rajasthan, India	Recruiting
SMS Hospital	Jaipur, Rajasthan, India	Not Yet Recruiting
KLE Belgum	Belagavi, India	Not Yet Recruiting
Post Graduate Institute of Medical Education & Research_Chandigarh	Chandigarh, India	Recruiting
Post Graduate Institute of Medical Education & Research_Chandigarh	Chandigarh, India	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07157423